These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4830142)

  • 21. Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
    Dean CJ; Hobbs SM; Hopkins JU; North SM; Styles JM
    Br J Cancer; 1982 Aug; 46(2):190-7. PubMed ID: 7150472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appearance of cytolytic antibodies in sheep lymph following immunisation with tumour cells. Identification of antibody subclasses.
    Grant CK; Adams EP; Nass M
    Aust J Exp Biol Med Sci; 1976 Oct; 53(5):381-7. PubMed ID: 820322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21.
    North SM; Gurin JL
    Immunology; 1989 Jan; 66(1):26-31. PubMed ID: 15493258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of rat hepatoma membrane fractions.
    Baldwin RW; Embleton MJ; Moore M
    Br J Cancer; 1973 Nov; 28(5):389-99. PubMed ID: 4357132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble tumour-specific antigen and its relationship to tumour growth.
    Thomson DM
    Int J Cancer; 1975 Jun; 15(6):1016-29. PubMed ID: 50290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M; Lawrence N; Nisbet NW
    Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between changes in antitumor immune parameters and tumor growth in vivo in rats.
    Bansal SC; Sjögren HO
    Fed Proc; 1973 Feb; 32(2):165-72. PubMed ID: 4347409
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro synthesis of tumor-specific factors with blocking and antibody-dependent cellular cytotoxicity (ADC) activities.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Dec; 16(6):932-41. PubMed ID: 1201873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and in-situ natural killer activity in tumour-bearing rats.
    Moore K; Moore M
    Br J Cancer; 1979 Jun; 39(6):636-47. PubMed ID: 375965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1976 Jan; 17(1):129-37. PubMed ID: 175021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific anti-tumor responses by cultured immune spleen cells. I. In vitro culture method and initial characterization of factors which block immune cell-mediated cytotoxicity in vitro.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 May; 15(5):806-14. PubMed ID: 1140873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
    Gautam SC; Deodhar SD
    Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity to MCA-induced rat sarcomas: analysis of in vivo and in vitro results.
    Harmon RC; Clark EA; Reddy AL; Hildemann WH; Mullen Y
    Int J Cancer; 1977 Nov; 20(5):748-58. PubMed ID: 924692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune responses to naturally occurring rat sarcomas.
    Embleton MJ; Middle JG
    Br J Cancer; 1981 Jan; 43(1):44-52. PubMed ID: 7459236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to chemically induced rat sarcomas: study of the specificity of cytotoxic cells.
    Goguel AF; Nauciel C
    Ann Immunol (Paris); 1979; 130C(5):621-34. PubMed ID: 316679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cell-free tumour-associated antigen preparations on the development of immunity to chemically induced rat tumours.
    Embleton MJ
    Int J Cancer; 1976 Nov; 18(5):622-9. PubMed ID: 791870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.
    Bowen JG; Robins RA; Baldwin RW
    Int J Cancer; 1975 Apr; 15(4):640-50. PubMed ID: 166943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.